Shockwave Medical, a pioneering force in the treatment of advanced cardiovascular disease, recently announced a monumental funding achievement of $13.1 million. This significant investment underscores the growing confidence in Shockwave's innovative approach to addressing calcified plaque, a common complication in cardiovascular conditions that can lead to severe health risks. The company鈥檚 breakthrough Intravascular Lithotripsy (IVL) technology is inspired by three decades of success in kidney stone treatment, merging safety and efficacy into the realm of cardiovascular care. By utilizing sonic pressure waves, Shockwave's IVL catheters precisely target and disrupt hardened calcium deposits without damaging surrounding soft tissue. This targeted disruption allows for the gentle balloon dilatation of stenotic arteries, effectively restoring blood flow with minimized risk. The capital raised will be instrumental in expanding the reach of Shockwave Medical鈥檚 transformative technology and accelerating research and development efforts to enhance patient outcomes and revolutionize the interventional landscape. With this funding, Shockwave Medical is poised to advance its mission of providing cutting-edge treatment options that significantly improve the quality of life for patients with advanced cardiovascular disease. Shockwave encourages stakeholders and interested parties to stay connected and informed about their advances at www.ShockwaveMedical.com and on Twitter @ShockwaveIVL, as they embark on this exciting new chapter in their journey to transform cardiovascular care.
Revolutionizing Cardiovascular Treatment: Shockwave Medical Secures $131 Million in Funding for Advanced Technology Development
Recently funded 路 $13.1BMedical Equipment Manufacturing
Get the full Shockwave Medical company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Antares
Energy abundance unlocks progress. It powers missions, grows economies, strengthens national security, and expands what鈥檚 possible on Earth and beyond. But in the places where power is most critical, it鈥檚 often the hardest to deliver. That鈥檚 the problem we鈥檙e solving. At Antares, we鈥檙e building compact nuclear microreactors to deliver reliable, mobile energy where it鈥檚 needed most: remote military bases, austere industrial sites, and, one day, deep space and underwater missions. The U.S. nuclear industry hasn鈥檛 seen true momentum in decades. We鈥檙e moving it forward with urgency, humility, and a commitment to building what鈥檚 needed now. Our team includes engineers and operators from SpaceX, Relativity Space, Ursa Major, the White House, MIT, Rigetti Computing, and the U.S. Air Force. Backed by over $130M from top-tier investors, we鈥檙e focused on shipping hardware not hypotheticals.
$470.0M Series c
today
Pilot Protocol
Virtual addresses, encrypted tunnels, and a trust model that works across any boundary. Open source. IETF drafts submitted. Built by Vulture Labs. Send your agent to pilotprotocol.network
